It is always difficult to give a prognosis, particularly without knowledge of the individual details of one’s medical history.
A general – generic – response: receiving a diagnosis of Parkinson’s disease in 2024 is not a disaster – and the prospects for symptom relief from many of the difficulties are good. REM sleep disorder may be due to a lack of dopamine or noradrenaline and is likely to improve with medication to treat these deficiencies.
Parkinson’s disease symptoms arise as a result of a dopamine deficiency, and medication such as L-dopa (e.g. Madopark/Sinemet or Stalevo) can restore and normalise dopamine production. It is also in line with the recommendations in modern guidelines to start treatment when symptoms that have led to the diagnosis are present. Treatment should begin with low doses, and the dose should be allowed to increase over a period of at least three months before the effect is assessed; however, some discomfort, such as a reduced appetite or seasickness-like nausea, may occur for a time at the start, but this is usually temporary. The benefits of dopamine replacement therapy generally outweigh the side effects.
/Håkan Widner